Three novel variants (p.G1u178Lys, p.Va1245Met, p.Ser250Phe) of the phenylalanine hydroxylase (PAH) gene impair protein expression and function in vitro
Three novel variants (p.G1u178Lys, p.Va1245Met, p.Ser250Phe) of the phenylalanine hydroxylase (PAH) gene impair protein expression and function in vitro
复制标题
苯丙氨酸羟化酶 (PAH) 基因的三种新变体(p.G1u178Lys、p.Va1245Met、p.Ser250Phe)在体外损害蛋白质表达和功能
作者:
Zong Y;Liu N;Ma S;Bai Y;Guan F;Kong X
Phenylketonuria (PKU) is the most common inherited metabolic disease, an autosomal recessive disorder affecting >10,000 newborns each year globally. It can be caused by over 1000 different naturally occurring mutations in the phenylalanine hydroxylase (PAH) gene. We analyzed three novel naturally occurringPAHgene variants: p.Glu178Lys (c.532G>A), p.Val245Met (c.733G>A) and p.Ser250Phe (c.749C>T). The mutant effect on the PAH enzyme structure and function was predicted by bioinformatics software. Vectors expressing the correspondingPAHvariants were generated for expression inE. coliand in HEK293T cells. The RNA expression of the threePAHvariants was measured by quantitative reverse transcription polymerase chain reaction (RT-qPCR). The mutant PAH protein levels were determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), western blot and enzyme-linked immunosorbent assay (ELISA). All three variants were predicted to be pathogenic by bioinformatics analysis. The transcription of the threePAHvariants was similar to the wild typePAHgene in HEK293T cells. In contrast, the levels of mutant PAH proteins decreased significantly compared to the wild type control, in bothE. coliand HEK293T cells. Our results indicate that the three novelPAHgene variants (p.Glu178Lys, p.Val245Met, p.Ser250Phe) impair PAH protein expression and function in prokaryotic and eukaryotic cells.